Table 1.
General data and baseline characteristics in the two groups
| Item | Experiment group (n = 62) | Control group (n = 61) | P |
|---|---|---|---|
| Age (years) | 83.16 ± 3.09 | 83.92 ± 2.85 | 0.161 |
| Gender (M/F) | 44/18 | 48/13 | 0.324 |
| BMI (kg/m2) | 23.95 ± 2.93 | 24.20 ± 3.22 | 0.646 |
| ADL (score) | 100 (95,100) | 100 (95,100) | 0.385 |
| Coronary heart disease (n [%]) | 22 (35.5) | 34 (55.7) | 0.024 |
| Cerebral vascular disease (n [%]) | 19 (30.6) | 21 (34.4) | 0.654 |
| Diabetes (n [%]) | 17 (27.4) | 30 (49.2) | 0.013 |
| COPD (n [%]) | 7 (11.3) | 5 (8.2) | 0.563 |
| CKD (n [%]) | 11 (17.7) | 15 (24.6) | 0.352 |
ADL, basic ADL assessment scale self‐care ability score; BMI, body mass index; cerebrovascular disease, cerebral ischemia or old cerebral infarction history; CKD, grade 3 of chronic kidney disease; COPD, chronic obstructive pulmonary disease (grade 1–3).